ilShinbiobase Co. Ltd (068330) — Cash Flow Reinvestment Rate
ilShinbiobase Co. Ltd (068330) has a Cash Flow Reinvestment Rate of 1.39x as of March 2026, reinvesting ₩4.79 Billion (capex ₩38.55 Million plus investments ₩-4.75 Billion) from operating cash flow of ₩3.46 Billion. For the full cash flow conversion analysis, see ilShinbiobase Co. Ltd cash flow conversion.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ilShinbiobase Co. Ltd Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for ilShinbiobase Co. Ltd across 12 annual periods. See financial flexibility index of ilShinbiobase Co. Ltd to measure the company's free cash flow as a share of total liabilities.
Annual Cash Flow Reinvestment Rate for ilShinbiobase Co. Ltd (2014–2025)
Year-by-year capital reinvestment analysis for ilShinbiobase Co. Ltd. See 068330 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.90x | ₩4.73 Billion | ₩5.27 Billion | ₩20.64 Million | ▼ -20.7% |
| 2024 | 1.13x | ₩4.66 Billion | ₩4.12 Billion | ₩53.53 Million | ▲ +15.3% |
| 2023 | 0.98x | ₩5.81 Billion | ₩5.92 Billion | ₩262.17 Million | ▼ -68.2% |
| 2022 | 3.09x | ₩8.18 Billion | ₩2.65 Billion | ₩522.59 Million | ▲ +14888.1% |
| 2021 | 0.02x | ₩139.12 Million | ₩6.74 Billion | ₩139.12 Million | ▼ -89.6% |
| 2020 | 0.20x | ₩892.64 Million | ₩4.50 Billion | ₩892.64 Million | ▼ -76.9% |
| 2019 | 0.86x | ₩4.77 Billion | ₩5.55 Billion | ₩245.41 Million | ▲ +140.1% |
| 2018 | 0.36x | ₩1.75 Billion | ₩4.88 Billion | ₩385.81 Million | ▲ +0.9% |
| 2017 | 0.35x | ₩749.79 Million | ₩2.11 Billion | ₩407.59 Million | ▼ -83.8% |
| 2016 | 2.19x | ₩6.59 Billion | ₩3.01 Billion | ₩271.94 Million | ▲ +101.5% |
| 2015 | 1.09x | ₩293.89 Million | ₩270.22 Million | ₩99.39 Million | ▲ +2627.6% |
| 2014 | 0.04x | ₩132.61 Million | ₩3.33 Billion | ₩101.50 Million | — |